Health research network TriNetX rakes in $40 mln Series D

Cambridge, Massachusetts-based TriNetX, a global health research network, has secured $40 million in Series D financing. Merck Global Health Innovation Fund led the round with participation from Mitsui & Co., Ltd., ITOCHU Technology Ventures, ITOCHU Corporation, MPM Capital, F2 Ventures and Deerfield Management.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!